반응식
[Cl:1][C:2]1[CH:3]=[N:4][C:5]2[N:6]([N:8]=[C:9]([C:11]([OH:13])=O)[CH:10]=2)[CH:7]=1.[CH3:14][O:15][C:16]1[CH:25]=[C:24]2[C:19]([CH2:20][CH2:21][NH:22][CH2:23]2)=[CH:18][C:17]=1[OH:26]>>[Cl:1][C:2]1[CH:3]=[N:4][C:5]2[N:6]([N:8]=[C:9]([C:11]([N:22]3[CH2:21][CH2:20][C:19]4[C:24](=[CH:25][C:16]([O:15][CH3:14])=[C:17]([OH:26])[CH:18]=4)[CH2:23]3)=[O:13])[CH:10]=2)[CH:7]=1참가 물질
3
실험 절차
In close analogy to the procedure described in Example 1, 6-chloro-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid is reacted with 7-methoxy-1,2,3,4-tetrahydro-isoquinolin-6-ol to provide the title compound as a solid.
출처 및 근거
- ORD 기록
- ord-d01a49c1316b43a2bc1d71981f29967e
- 출처 데이터셋
- uspto-grants-2011_07
- 특허 번호
- US07985753B2
연결된 노트
불러오는 중…